Therefore, it was speculated that the ATII-CCL20 cell subtype was regulated by abnormal stromal cells through its receptor expressing TGFB2, leading to functional changes and affecting the prognosis of IPF patients (Fig. 4B). The gene discussed is CCL20; the disease is idiopathic pulmonary fibrosis.